Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study - Colin J. Adams, Shane Shapera, Christopher J. Ryerson, Deborah Assayag, Kerri A. Johannson, Charlene D. Fell, Julie Morisset, Hélène Manganas, Martin Kolb, Nathan Hambly, Gerard Cox, Nasreen Khalil, Veronica Marcoux, Pearce G. Wilcox, Teresa To - Dissemin

Language
Login

Published in

Elsevier, Respiratory Medicine, (191), p. 106722, 2022

DOI: 10.1016/j.rmed.2021.106722

Links

Elsevier

Tools

Export citation

Search in Google Scholar

Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study

Journal article published in 2022 by Colin J. Adams, Shane Shapera, Christopher J. Ryerson, Deborah Assayag, Kerri A. Johannson, Charlene D. Fell, Julie Morisset, Hélène Manganas, Martin Kolb, Nathan Hambly, Gerard Cox, Nasreen Khalil, Veronica Marcoux, Pearce G. Wilcox, Teresa To and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO

Beta version